DePuy Orthopaedics Inc. Acquires Finsbury Orthopaedics Limited
July 28, 2016 at 4:25 p.m.
By Staff Report-
Financial terms of the transaction were not disclosed.
With the acquisition of Finsbury Orthopaedics, DePuy gains several key products, including the DeltaMotion® Ceramic-on-Ceramic Hip System, the ADEPT® Metal-on-Metal Hip Resurfacing and Total Hip System, as well as the Medial Rotation Knee System, the Dual Bearing Knee System, the BOX® Total Ankle Replacement, Tuke Saw and multiple small joint reconstructive implant lines.
DePuy Orthopaedics leads the worldwide hip market in providing a range of high-stability, low-wear total hip implants. Finsbury Orthopaedics has pioneered advanced high performance, large diameter hip bearings that feature proprietary ceramic-on-ceramic and metal-on-metal bearing technologies designed to address the unmet needs of active patients. With the addition of the ADEPT and DeltaMotion platforms to DePuy's existing portfolio of advanced high performance hip bearings, DePuy offers a range of hip bearing options for clinicians worldwide.[[In-content Ad]]
Financial terms of the transaction were not disclosed.
With the acquisition of Finsbury Orthopaedics, DePuy gains several key products, including the DeltaMotion® Ceramic-on-Ceramic Hip System, the ADEPT® Metal-on-Metal Hip Resurfacing and Total Hip System, as well as the Medial Rotation Knee System, the Dual Bearing Knee System, the BOX® Total Ankle Replacement, Tuke Saw and multiple small joint reconstructive implant lines.
DePuy Orthopaedics leads the worldwide hip market in providing a range of high-stability, low-wear total hip implants. Finsbury Orthopaedics has pioneered advanced high performance, large diameter hip bearings that feature proprietary ceramic-on-ceramic and metal-on-metal bearing technologies designed to address the unmet needs of active patients. With the addition of the ADEPT and DeltaMotion platforms to DePuy's existing portfolio of advanced high performance hip bearings, DePuy offers a range of hip bearing options for clinicians worldwide.[[In-content Ad]]
Have a news tip? Email [email protected] or Call/Text 360-922-3092